TMCnet News

Announcement from Tobii's Extraordinary General Meeting
[November 30, 2016]

Announcement from Tobii's Extraordinary General Meeting


Regulatory News:

At today´s Extraordinary General Meeting ("EGM") in Tobii AB (publ) (the "Company" or "Tobii") (STO:TOBII), the following resolution was adopted. The board of directors' complete proposals have previously been published and are available at the Company's website, www.tobii.com.

The EGM resolved to approve the resolution by the board of directors to increase the share capital of the Company by a maximum of SEK 63,962.63 through the issue of a maximum of 8,814,003 shares. The new shares shall be subscribed for with preferential rights of existing shareholders of the Company in proportion to the number of existing shares held at the record date. One (1) subscription right will be received for each existing share. Ten (10) subscription rights entitle the holder to subscribe for one (1) new share. The record date for determining which shareholders shall be entitled to the preferential right to subscribe for new shares shall be December 2, 2016. The subscription priceis set to SEK 52 for each new share, which is expected to raise proceeds of approximately SEK 458 million to the Company, before issue costs and assuming that the rights issue is fully subscribed. Subscription shall take place during the period from December 6, 2016 up to and including December 20, 2016.



This information is information that Tobii AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, on November 30, 2016, at 4:30 p.m. CET.

About Tobii


Tobii is the global leader in eye tracking. Our vision is a world where all technology works in harmony with natural human behavior. Tobii operates through three business units: Tobii Dynavox makes specially designed computers that are controlled by eye movement or touch screens for use by people with special needs due to spinal cord injuries, CP, ALS or other medical conditions. Tobii Pro develops and sells eye-tracking equipment and services used today by more than 3,000 companies and 2,000 research institutions, including all of the world's 50 highest ranked universities. Tobii Tech further develops Tobii's technology for new volume markets, such as computer games, personal computers, virtual reality and vehicles. Tobii is headquartered in Sweden and is listed on Nasdaq Stockholm (TOBII). The group has over 700 employees. For more information, please visit www.tobii.com.

This information was brought to you by Cision http://news.cision.com


[ Back To TMCnet.com's Homepage ]